·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ [¿µ»ó]ÃÖ´ëÁý ȸÀå, ³× ¹ø° »è¹ß "¼ö°¡Àλó ÀÇÁö º¸¿©¶ó" ±â»çÀÔ·Â : 19.06.28 15:45:06 0 °¡ ÇÃÄ£Ãß°¡ °ÇÁ¤½É ¾ÕµÎ°í ½ÉÆò¿ø ¼¿ï»ç¹«¼Ò¿¡¼ ±âÀÚȸ°ß °°Àº ½Ã°£ ½Ã¹Î´Üü´Â "°Çº¸ ±¹°íÁö¿ø ´çÀå ÀÌÇàÇ϶ó" ¸ñ¼Ò¸® ³ô¿© ±¤°íÁÖ»çÀÌÆ®¹æ¹®Çϱâ 28ÀÏ ¿ÀÈÄ 2½Ã, ³»³âµµ µ¿³× ÀÇ¿ø ¼ö°¡¿Í ±¹¹Î °Ç°º¸Çè·á Àλó·üÀ» °áÁ¤ÇÒ °Ç°º¸ÇèÁ¤Ã¥½ÉÀÇÀ§¿øȸ(ÀÌÇÏ °ÇÁ¤½É)¸¦ ¾ÕµÎ°í ÃÖ´ëÁý ´ëÇÑÀÇ»çÇùȸÀåÀÌ ¼ö°¡ Àλó°ú °Ç°º¸ÇèÁ¾ÇÕ°èȹÀÇ Ã¶È¸¸¦ ¿ä±¸ÇÏ¸ç »è¹ß½ÄÀ» ÁøÇàÇß´Ù. ±èÁø±¸ ±âÀÚ(kjg@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · ÀÇÇù "ÀÇ¿ø ¼ö°¡ 3.5% ¸¶Áö³ë¼±"...°¡ÀÔÀÚ "2.9%µµ... Medical Information Associate ¹Ù·Î°¡±â External Engagement Partner ¹Ù·Î°¡±â R&DºÎ¼ °æ·ÂÁ÷ ¾à»ç¸ðÁý (¼¿ïÁö»ç) ¹Ù·Î°¡±â [Çѵ¶] RA/CRA(°è¾àÁ÷)/°Ç°±â´É½ÄÇ° ¿¬±¸¿ø/HSE ÆÀÀå/IT º¸¾È ´ã´ç/°ü¸®¾à»ç/Corporate Development ¹Ù·Î°¡±â °Ç°±â´É½ÄÇ° ¾à±¹À¯Åë ÀÚ¹®/Çмú ¾à»ç ¸ðÁý ¹Ù·Î°¡±â RA, PV µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â Çѱ¹¾Ï¿þÀÌ R&D ºÎ¼ Technical Regulatory Analystä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : [¿µ»ó]ÃÖ´ëÁý ȸÀå, ³× ¹ø° »è¹ß ¼ö°¡Àλó ÀÇÁö º¸¿©¶ó URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ [¿µ»ó]ÃÖ´ëÁý ȸÀå, ³× ¹ø° »è¹ß "¼ö°¡Àλó ÀÇÁö º¸¿©¶ó" ±â»çÀÔ·Â : 19.06.28 15:45:06 0 °¡ ÇÃÄ£Ãß°¡ °ÇÁ¤½É ¾ÕµÎ°í ½ÉÆò¿ø ¼¿ï»ç¹«¼Ò¿¡¼ ±âÀÚȸ°ß °°Àº ½Ã°£ ½Ã¹Î´Üü´Â "°Çº¸ ±¹°íÁö¿ø ´çÀå ÀÌÇàÇ϶ó" ¸ñ¼Ò¸® ³ô¿© ±¤°íÁÖ»çÀÌÆ®¹æ¹®Çϱâ 28ÀÏ ¿ÀÈÄ 2½Ã, ³»³âµµ µ¿³× ÀÇ¿ø ¼ö°¡¿Í ±¹¹Î °Ç°º¸Çè·á Àλó·üÀ» °áÁ¤ÇÒ °Ç°º¸ÇèÁ¤Ã¥½ÉÀÇÀ§¿øȸ(ÀÌÇÏ °ÇÁ¤½É)¸¦ ¾ÕµÎ°í ÃÖ´ëÁý ´ëÇÑÀÇ»çÇùȸÀåÀÌ ¼ö°¡ Àλó°ú °Ç°º¸ÇèÁ¾ÇÕ°èȹÀÇ Ã¶È¸¸¦ ¿ä±¸ÇÏ¸ç »è¹ß½ÄÀ» ÁøÇàÇß´Ù. ±èÁø±¸ ±âÀÚ(kjg@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · ÀÇÇù "ÀÇ¿ø ¼ö°¡ 3.5% ¸¶Áö³ë¼±"...°¡ÀÔÀÚ "2.9%µµ... Medical Information Associate ¹Ù·Î°¡±â External Engagement Partner ¹Ù·Î°¡±â R&DºÎ¼ °æ·ÂÁ÷ ¾à»ç¸ðÁý (¼¿ïÁö»ç) ¹Ù·Î°¡±â [Çѵ¶] RA/CRA(°è¾àÁ÷)/°Ç°±â´É½ÄÇ° ¿¬±¸¿ø/HSE ÆÀÀå/IT º¸¾È ´ã´ç/°ü¸®¾à»ç/Corporate Development ¹Ù·Î°¡±â °Ç°±â´É½ÄÇ° ¾à±¹À¯Åë ÀÚ¹®/Çмú ¾à»ç ¸ðÁý ¹Ù·Î°¡±â RA, PV µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â Çѱ¹¾Ï¿þÀÌ R&D ºÎ¼ Technical Regulatory Analystä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : [¿µ»ó]ÃÖ´ëÁý ȸÀå, ³× ¹ø° »è¹ß ¼ö°¡Àλó ÀÇÁö º¸¿©¶ó URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ [¿µ»ó]ÃÖ´ëÁý ȸÀå, ³× ¹ø° »è¹ß "¼ö°¡Àλó ÀÇÁö º¸¿©¶ó" ±â»çÀÔ·Â : 19.06.28 15:45:06 0 °¡ ÇÃÄ£Ãß°¡ °ÇÁ¤½É ¾ÕµÎ°í ½ÉÆò¿ø ¼¿ï»ç¹«¼Ò¿¡¼ ±âÀÚȸ°ß °°Àº ½Ã°£ ½Ã¹Î´Üü´Â "°Çº¸ ±¹°íÁö¿ø ´çÀå ÀÌÇàÇ϶ó" ¸ñ¼Ò¸® ³ô¿© ±¤°íÁÖ»çÀÌÆ®¹æ¹®Çϱâ 28ÀÏ ¿ÀÈÄ 2½Ã, ³»³âµµ µ¿³× ÀÇ¿ø ¼ö°¡¿Í ±¹¹Î °Ç°º¸Çè·á Àλó·üÀ» °áÁ¤ÇÒ °Ç°º¸ÇèÁ¤Ã¥½ÉÀÇÀ§¿øȸ(ÀÌÇÏ °ÇÁ¤½É)¸¦ ¾ÕµÎ°í ÃÖ´ëÁý ´ëÇÑÀÇ»çÇùȸÀåÀÌ ¼ö°¡ Àλó°ú °Ç°º¸ÇèÁ¾ÇÕ°èȹÀÇ Ã¶È¸¸¦ ¿ä±¸ÇÏ¸ç »è¹ß½ÄÀ» ÁøÇàÇß´Ù. ±èÁø±¸ ±âÀÚ(kjg@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : [¿µ»ó]ÃÖ´ëÁý ȸÀå, ³× ¹ø° »è¹ß ¼ö°¡Àλó ÀÇÁö º¸¿©¶ó URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö